3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
43
Terminated
25
Recruiting
16
Active not recruiting
12
Unknown
5
Withdrawn
3
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
15
OTHER_GOV
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Carcinoma, Non-Small-Cell Lung
77
Breast Neoplasms
53
Colorectal Neoplasms
52
Neoplasms
40
Advanced Solid Tumors
34
Prostatic Neoplasms
31
Multiple Myeloma
31
Ovarian Neoplasms
28
Neoplasm Metastasis
28
Recurrence
27
Lung Neoplasms
27
Carcinoma, Hepatocellular
27
Pancreatic Neoplasms
26
Advanced Solid Tumor
22
Small Cell Lung Carcinoma
20
Leukemia, Myeloid, Acute
20
Melanoma
18
Endometrial Neoplasms
18
Triple Negative Breast Neoplasms
17
Squamous Cell Carcinoma of Head and Neck
14
Lymphoma, Follicular
14
Stomach Neoplasms
13
Lymphoma, B-Cell
13
Glioma
13
Glioblastoma
13
Uterine Cervical Neoplasms
12
Lymphoma
11
Head and Neck Neoplasms
11
Solid Tumor
10
Myasthenia Gravis
9
Interventions
Phlebotomy
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
INDUSTRY
×
Myeloproliferative Disorders
×
Clear all
NCT06290765
2025-07-31
PV
PharmaEssentia
Phase 4
Not yet recruiting
70 enrolled